199
An AI-powered clinical trial management system for pharma companies and research organizations running remote, hybrid, and onsite studies with African participants.

Infiuss Health is an AI-powered clinical trial management system (CTMS) for pharmaceutical companies, CROs, research sponsors, and academic researchers running remote, hybrid, and onsite clinical studies across Africa.
Key capabilities include:
Available on Web via a dashboard.
Targeted at conducting trials in Africa, including pharma companies, contract research organizations (CROs), sponsors, and academic research groups.
Notable in the African market context for supporting decentralized trial models and for a stated focus on improving representation of historically underrepresented African populations in clinical research. The company has also disclosed rapid, multi-country study execution examples (including studies completed across four countries).
DD Dave found 1 key person at Infiuss Health, including 1 Founder. See how we get product data
No reviews yet. Be the first to review this product.
DD Dave found that Infiuss Health has raised $580K across 5 rounds, backed by 17 investors. Their latest round was a Venture (Round not Specified) in Sep 2022. See how we get product data